Skip to Content

Clinical Trial Detail


Patient Information

A Randomized Phase II Study of VTX-2337 (IND #78,416) in combination with pegylated liposomal doxorubicin (PLD) vs. PLD alone in the treatment of recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cance

Study Number

Clinical Trial Categories

  • Ovarian Cancer


  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725


Large Conference Room: Please enter the building through the door to the right of the main entrance…this door is a direct entrance to our meeting room. The Valet service is operating at our main entrance for our patients.

Also in this Section